No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CVS Health (CVS) Stock Moves -0.09%: What You Should Know
Under the Radar: Undervalued Assets Wall Street Isn't Talking About
Zydus Announces Agreement With CVS Caremark to Add Zituvio and Combination Products to Its Template Formulary
Express News | Zydus Announces Agreement With CVS Caremark to Add Zituvio™, Zituvimet™ and Zituvimet™ Xr (Sitagliptin | Sitagliptin and Metformin Hydrochloride) to Its Template Formulary
Should Walgreens Stock Be in Your Portfolio Before Q1 Earnings?
BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $63